CDK4 and thyroid cancer: Recent study indicated that miR-539 inhibits thyroid cancer cell migration and invasion by directly targeting CARMA1 [40], induces cell cycle arrest in nasopharyngeal carcinoma by targeting cyclin-dependent kinase 4 [41].